PharmiWeb.com - Global Pharma News & Resources
30-Oct-2018

Global Non-Hodgkin Lymphoma Therapeutics Market Analysis 2018-2025 - ResearchAndMarkets.com

The "Global Non-Hodgkin Lymphoma Therapeutics Market Analysis 2018 - Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.

The report contains up to date financial data derived from varied research sources to present unique and reliable analysis.

Assessment of major trends with potential impact on the market during the next eight years, including a deep dive analysis of market segmentation which comprises of sub markets, regional and country level analysis.

The report provides a comprehensive outlook about the market share along with strategic recommendations based on the emerging segments.

This report provides:

  • Market sizing estimations and forecasts across the given market segments
  • Identifying market dynamics (Drivers, Restraints, Opportunities, Threats, Challenges)
  • Strategic recommendations in key business segments based on the market estimations
  • Regional and country level market analysis
  • Competitive landscaping of major market players
  • Company profiling covering the financials, recent activities and the future strategies

Key Topics Covered

1 Introduction

2 Executive Summary

3 Market Analysis

4 Porters Five Force Analysis

5 Non-Hodgkin Lymphoma Therapeutics Market by Therapeutics

6 Non-Hodgkin Lymphoma Therapeutics Market by Cancer Type

7 Non-Hodgkin Lymphoma Therapeutics Market by Type

8 Non-Hodgkin Lymphoma Therapeutics Market by Cell Type

9 Geographical Segmentation

10 Vendor Landscaping

11 Company Profiles

  • Novartis
  • Merck
  • F. Hoffman La-Roche Ltd.
  • GlaxoSmithKline PLC
  • Bristol Myers Squibb Co.
  • Bayer AG
  • Pfizer
  • CTI Biopharma
  • Kyowa Hakko Kirin
  • Pharmacyclics/Janssen Biotech
  • Millennium/Johnson-Johnson
  • Celgene
  • Spectrum Pharmaceuticals
  • Seattle Genetics

For more information about this report visit https://www.researchandmarkets.com/research/vds6xt/global?w=4

View source version on businesswire.com: https://www.businesswire.com/news/home/20181030005734/en/

Editor Details

Last Updated: 30-Oct-2018